|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.173 SEK | -0.59% |
|
+1.94% | -47.19% |
| 06-26 | Cantargia: Study Bolsters IL1RAP as a Target in Pancreatic Cancer | FW |
| 06-26 | Cantargia Announces Publication Of Data Supporting IL1RAP As A Therapeutic Target And Predictive Biomarker In PDAC | CI |
| Market Cap | 543M 56.35M 49.26M 45.27M 42.2M 80.03M 5.37B 81.25M 211M 2.64B 212M 207M 9.09B | P/E 2026 * |
-2.84x | P/E 2027 * | -2.57x |
|---|---|---|---|---|---|
| Enterprise Value | 543M 56.35M 49.26M 45.27M 42.2M 80.03M 5.37B 81.25M 211M 2.64B 212M 207M 9.09B | EV / Sales 2026 * |
518x | EV / Sales 2027 * | 14.2x |
| Free-Float |
83.04% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cantargia AB
| 1 day | -0.55% | ||
| 1 week | +1.94% | ||
| Current month | +2.98% | ||
| 1 month | +8.02% | ||
| 3 months | -43.79% | ||
| 6 months | -50.67% | ||
| Current year | -47.19% |
| 1 week | 2.1 |  | 2.22 |
| 1 month | 1.86 | | 2.3 |
| Current year | 1.86 | | 6.59 |
| 1 year | 1.13 | | 6.59 |
| 3 years | 1 | | 6.59 |
| 5 years | 1 | | 27.92 |
| 10 years | 1 | | 71.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 60 | 2025-08-31 | |
Patrik Renblad
DFI | Director of Finance/CFO | 56 | 2023-06-14 |
Wolfram Dempke
CTO | Chief Tech/Sci/R&D Officer | - | 2025-10-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2015-12-31 | |
| Director/Board Member | 55 | 2017-12-31 | |
Flavia Borellini
BRD | Director/Board Member | 64 | 2020-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-25 | Buy | Director | 14,012 | 0.0056% | ||
| 06-25 | Buy | Director | 63,054 | 0.0254% | ||
| 06-24 | Buy | 4,444 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | +1.94% | +69.74% | -40.72% | 56.35M | |
| -0.22% | +5.55% | +77.94% | +135.65% | 59.1B | |
| +2.32% | +5.03% | +75.26% | +92.31% | 55.19B | |
| +3.86% | +6.93% | -11.32% | -10.57% | 24.67B | |
| +4.30% | +7.95% | +14.11% | +440.44% | 24.19B | |
| +0.69% | +7.31% | +51.14% | -0.89% | 19.69B | |
| -0.07% | +8.64% | +42.74% | -28.08% | 17.56B | |
| 0.00% | +20.78% | +186.15% | +347.42% | 16.22B | |
| +5.51% | +20.41% | +48.84% | - | 14.84B | |
| +3.50% | +1.97% | +21.02% | +193.33% | 14.04B | |
| Average | +1.90% | +7.90% | +57.56% | +125.43% | 24.55B | |
| Weighted average by Cap. | +1.85% | +6.47% | +59.55% | +135.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.05M 109K 95.17K 87.46K 81.52K 155K 10.37M 157K 408K 5.1M 409K 400K 17.56M | 38.35M 3.98M 3.48M 3.19M 2.98M 5.65M 379M 5.73M 14.91M 186M 14.93M 14.6M 641M |
| Net income | -179M -18.59M -16.25M -14.93M -13.92M -26.4M -1.77B -26.8M -69.68M -870M -69.76M -68.26M -3B | -180M -18.63M -16.28M -14.96M -13.95M -26.46M -1.77B -26.86M -69.84M -872M -69.92M -68.42M -3B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | SEK 2.180 | -0.27% | 44,517 |
| 26-07-03 | SEK 2.186 | +0.74% | 381,071 |
| 26-07-02 | SEK 2.170 | +3.14% | 702,720 |
| 26-07-01 | SEK 2.104 | -1.96% | 298,134 |
| 26-06-30 | SEK 2.146 | -1.01% | 250,742 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CANTA Stock
Select your edition
All financial news and data tailored to specific country editions
